El talent humà del campus

Què busques?

Common searches: Malaltia, Cirugia, Cita previa,

L’actualitat del campus

Microscopi Fàrmac EB1

New drug could improve response to cancer treatments

06/07/2022

The drug EB1 is able to block resistance pathways to standard cancer treatments and could increase the efficacy of chemotherapy or immunotherapy.

h
El campus en xifres

9,000

9K

Professionals

1,200

1K

Pacients a l'any

80

80

Grups de recerca

Documents relacionats

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed vehicula posuere placerat. Cras vel turpis ac nisl egestas cursus. Suspendisse eu consequat mi. Aliquam tempor dolor id viverra ornare. Nam mollis lacus vitae mi lobortis, vel rhoncus purus elementum. Pellentesque lobortis consequat nunc eget iaculis.

h

2021

Nova Web

Nova Web

h

2022

Nova Web

Nova Web

Subscribe to our newsletters and be a part of Vall d'Hebron Campus

Select the newsletter you want to receive:

By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to web@vhebron.net, clearly stating the subject as "Exercising of Data Protection Rights".
Operated by: Vall d’Hebron University Hospital Foundation – Research Institute.
Purpose: Manage the user’s contact information.
Legitimisation: Express acceptance of the privacy policy.
Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use.
Source: The interested party themselves.